We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
+8.03%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$1.26B
AUM Growth
+$69.7M
Cap. Flow
+$21.1M
Cap. Flow %
1.68%
Top 10 Hldgs %
3.22%
Holding
2,074
New
640
Increased
457
Reduced
456
Closed
520

Top Buys

Rank Stock Value
1
ZTS icon
Zoetis
ZTS
+$3.54M
2
MNST icon
Monster Beverage
MNST
+$3.4M
3
UGI icon
UGI
UGI
+$3.25M
4
LMND icon
Lemonade
LMND
+$3.18M
5
APA icon
APA Corp
APA
+$3.05M

Top Sells

Rank Stock Value
1
CRH icon
CRH
CRH
+$4.73M
2
AON icon
Aon
AON
+$4.58M
3
ZG icon
Zillow
ZG
+$4.44M
4
URNM icon
Sprott Uranium Miners ETF
URNM
+$4.08M
5
BWXT icon
BWX Technologies
BWXT
+$3.63M

Sector Composition

Rank Sector Weight
1 Technology 15.86%
2 Financials 12.61%
3 Healthcare 12.06%
4 Consumer Discretionary 11.89%
5 Industrials 9.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FAF icon
1301
First American
FAF
$7.58B
$252K 0.02%
+4,132
New +$244K
RVMD icon
1302
Revolution Medicines
RVMD
$44B
$251K 0.02%
+7,801
New +$231K
KMT icon
1303
Kennametal
KMT
$2.52B
$250K 0.02%
+10,018
New +$247K
MREO
1304
Mereo BioPharma
MREO
$47.3M
$250K 0.02%
+75,787
New +$257K
SUPN icon
1305
Supernus Pharmaceuticals
SUPN
$2.77B
$249K 0.02%
7,294
-1,031
-12% -$30.7K
NPK icon
1306
National Presto Industries
NPK
$989M
$248K 0.02%
+2,964
New +$234K
USAC icon
1307
USA Compression Partners
USAC
$3.74B
$248K 0.02%
+9,304
New +$237K
VVV icon
1308
Valvoline
VVV
$4.51B
$248K 0.02%
5,554
-41,818
-88% -$1.67M
LMAT icon
1309
LeMaitre Vascular
LMAT
$1.86B
$247K 0.02%
3,720
-6,105
-62% -$377K
MEDP icon
1310
Medpace
MEDP
$16.5B
$247K 0.02%
+611
New +$215K
CCNE icon
1311
CNB Financial Corp
CCNE
$1.03B
$246K 0.02%
12,087
-10,428
-46% -$216K
WMPN
1312
DELISTED
William Penn Bancorporation Common Stock
WMPN
$246K 0.02%
19,918
+3,883
+24% +$47.5K
OLO
1313
DELISTED
Olo Inc
OLO
$245K 0.02%
44,606
-121,337
-73% -$662K
RHI icon
1314
Robert Half
RHI
$4.37B
$245K 0.02%
+3,088
New +$249K
SUM
1315
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
$245K 0.02%
5,491
-31,803
-85% -$1.26M
CLOV icon
1316
Clover Health Investments
CLOV
$2.51B
$244K 0.02%
307,728
+56,138
+22% +$51.1K
GNR icon
1317
State Street SPDR S&P Global Natural Resources ETF
GNR
$4.87B
$244K 0.02%
+4,219
New +$229K
RPRX icon
1318
Royalty Pharma
RPRX
$25.3B
$244K 0.02%
8,041
-6,196
-44% -$183K
SGMO
1319
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$244K 0.02%
364,284
-711,406
-66% -$516K
VEEV icon
1320
Veeva Systems
VEEV
$37.4B
$244K 0.02%
+1,051
New +$227K
HAFC icon
1321
Hanmi Financial
HAFC
$946M
$243K 0.02%
15,283
-75,464
-83% -$1.23M
NXST icon
1322
Nexstar Media Group
NXST
$5.97B
$243K 0.02%
+1,409
New +$237K
CVLT icon
1323
Commault Systems
CVLT
$5.61B
$242K 0.02%
2,383
-7,209
-75% -$652K
GSIT icon
1324
GSI Technology
GSIT
$258M
$242K 0.02%
+71,042
New +$205K
LAZR
1325
DELISTED
Luminar Technologies
LAZR
$242K 0.02%
+8,177
New +$298K
51 52
53
54 55

Similar funds

NCL
Nishkama Capital LLC Dorado, Puerto Rico $1.58B AUM 123.32% 1-Year Est. Return
DG
DigitalBridge Group Boca Raton, Florida $1.58B AUM 62.54% 1-Year Est. Return
VNT
Vanguard National Trust Malvern, Pennsylvania $1.59B AUM
SS
Sunbelt Securities Houston, Texas $1.58B AUM 28.96% 1-Year Est. Return
GWANC
Guardian Wealth Advisors (North Carolina) Raleigh, North Carolina $1.59B AUM 15.17% 1-Year Est. Return
LCM
Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return
LCM
Landscape Capital Management Englewood, New Jersey $1.58B AUM 26.88% 1-Year Est. Return
FDCP
Foster Dykema Cabot & Partners Waltham, Massachusetts $1.57B AUM 20.41% 1-Year Est. Return

GSA Capital Partners's Q1 2024 Portfolio in Review

As of Q1 2024, GSA Capital Partners held 2,074 positions worth $1.26B, up 5.9% from $1.19B the previous quarter. Its ten largest holdings account for 3.2% of the portfolio.

GSA Capital Partners's Q1 2024 filing shows 640 new, 457 increased, 456 reduced and 520 closed positions. Its largest new stake was Zoetis: 18,907 shares worth $3.2M. The largest sale was CRH, an estimated $4.73M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.

  • GSA Capital Partners's largest Q1 2024 buy was Zoetis: 18,907 shares worth $3.2M.
  • GSA Capital Partners added most to Monster Beverage in Q1 2024, an estimated $3.4M increase.
  • GSA Capital Partners's biggest Q1 2024 reduction was CRH, cutting an estimated $4.73M.
  • GSA Capital Partners fully exited Aon in Q1 2024, selling an estimated $4.58M.
  • GSA Capital Partners's ten largest holdings make up 3.2% of its $1.26B portfolio in Q1 2024.
  • GSA Capital Partners opened 640 new positions and closed 520 in Q1 2024.
  • GSA Capital Partners's portfolio value rose 5.9% quarter-over-quarter to $1.26B.

Based on GSA Capital Partners's 13F filing for Q1 2024, filed 3 May 2024.